doi: 10.1136/jech.30.1.40.
Screening for spina bifida cystica. A cost-benefit analysis
- PMID: 59616
- PMCID: PMC478937
- DOI: 10.1136/jech.30.1.40
Item in Clipboard
Screening for spina bifida cystica. A cost-benefit analysis
Br J Prev Soc Med.
1976 Mar.
Abstract
The costs and economic benefits are examined of introducing a programme for the mass-screening of pregnancies for the detection and abortion of fetuses with spina bifida cystica. A benefit-cost index is derived, and the possible effects on it of making different input assumptions are discussed. It is considered that, on economic grounds, screening may be worthwhile only in populations in which the incidence of spina bifida is high.
Similar articles
-
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.Lancet. 1977 Jun 25;1(8026):1323-32. Lancet. 1977. PMID: 69055
-
Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.Am J Obstet Gynecol. 1999 May;180(5):1227-33. doi: 10.1016/s0002-9378(99)70621-6. Am J Obstet Gynecol. 1999. PMID: 10329882
-
[Letter: The role of the study of alpha fetoproteins in the amniotic fluid in the prevention anencephaly and spina bifida].Orv Hetil. 1975 May 18;116(20):1191. Orv Hetil. 1975. PMID: 49037 Hungarian. No abstract available.
-
The reduction of anencephalic and spina bifida births by maternal serum alphafetoprotein screening.Br Med Bull. 1983 Oct;39(4):365-72. doi: 10.1093/oxfordjournals.bmb.a071849. Br Med Bull. 1983. PMID: 6196071 Review. No abstract available.
-
[Alpha fetoproteins (AFP) in prenatal diagnosis of anencephalus and spina bifida. Resumé and selection from current literature].Rev Chil Obstet Ginecol. 1974;39(1):23-31. Rev Chil Obstet Ginecol. 1974. PMID: 4143398 Review. Spanish. No abstract available.
Cited by
-
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.Hum Genet. 1985;69(1):47-61. doi: 10.1007/BF00295529. Hum Genet. 1985. PMID: 2578423
-
When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?CMAJ. 1987 Feb 1;136(3):255-65. CMAJ. 1987. PMID: 2433011 Free PMC article.
-
Measuring the benefits of screening for open neural tube defects.J Epidemiol Community Health. 1982 Sep;36(3):214-9. doi: 10.1136/jech.36.3.214. J Epidemiol Community Health. 1982. PMID: 6815296 Free PMC article.
-
Hazards of prenatal detection of neural-tube defects by screening maternal serum for alpha-fetoprotein.Can Med Assoc J. 1978 May 20;118(10):1186-91. Can Med Assoc J. 1978. PMID: 77179 Free PMC article. No abstract available.
-
Essentials of health economics. Part V--Assessing the costs and benefits of treatment alternatives.Br Med J (Clin Res Ed). 1982 Nov 27;285(6354):1561-3. doi: 10.1136/bmj.285.6354.1561. Br Med J (Clin Res Ed). 1982. PMID: 6814645 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources